Skip to main content
Terug
Watch Compare

Insight Molecular Diagnostics Inc.

Datakwaliteit: 100%
IMDX
NASDAQ Manufacturing Chemicals
€ 3,17
▼ € 0,01 (-0,31%)
Marktkapitalisatie: 99,40 M
Prijs
€ 3,09
Marktkapitalisatie
99,40 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -14,89% annually over 5 years
Negative free cash flow of -25,37 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 130,47%
Capital intensive — 78,55% of revenue goes to capex

Groei

Revenue Growth (5Y)
-14,89%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)115,58%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-100,79%
Net Margin-1238,52%
Op. Margin-1260,76%

Veiligheid

Debt / Equity
N/A
Current Ratio2,79
Interest Coverage-469,03

Waardering

PE (TTM)
-1,98
Onder sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -2,0 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % -1238,5 -41,5
Rev Growth 5Y % -14,9 1,8
D/E — 0,3

Koersdoel Analisten

3 analisten
Buy
Huidig
€ 3,17
+162.9%
Koersdoel
€ 8,33
€ 4,00
€ 9,00
€ 12,00
Vooruitzicht
Forward WPA -€ 0,87
Omzet Sch. 8,17 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,87
-€ 0,96 – -€ 0,79
 8,17 M 4
FY2026 -€ 0,75
-€ 1,03 – -€ 0,21
 2,58 M 4

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,24 -€ 0,72 -203,2%
Q32025 -€ 0,24 -€ 0,23 +2,8%
Q22025 -€ 0,24 -€ 0,30 -25,0%
Q12025 -€ 0,25 -€ 0,23 +9,8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 115,58% Revenue Growth (3Y) 64,25%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -14,89% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4,06 M Net Income (TTM) -50,22 M
ROE N/A ROA -106,34%
Gross Margin 56,67% Operating Margin -1260,76%
Net Margin -1238,52% Free Cash Flow (TTM) -25,37 M
ROIC -100,79% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,79
Interest Coverage -469,03 Asset Turnover 0,09
Working Capital 13,73 M Tangible Book Value -23,80 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,98 Forward P/E N/A
P/B Ratio N/A P/S Ratio 24,51
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 12,16 Fwd Earnings Yield N/A
FCF Yield -25,52%
Market Cap 99,40 M Enterprise Value 80,71 M
Per Share
EPS (Diluted TTM) -1,65 Revenue / Share 0,13
FCF / Share -0,79 OCF / Share -0,69
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 78,55% FCF Conversion 50,51%
SBC-Adj. FCF -27,32 M Growth Momentum 130,47

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4,06 M 1,88 M 1,50 M 958.000,0 7,73 M
Net Income -50,22 M -60,66 M -27,78 M -72,90 M -64,10 M
EPS (Diluted) -1,65 -4,66 -3,75 — —
Gross Profit 2,30 M 740.000,0 413.000,0 -18.000,0 188.000,0
Operating Income -51,12 M -61,04 M -25,14 M -18,00 M -74,21 M
EBITDA — — — — —
R&D Expenses 15,90 M 9,84 M 9,29 M 7,30 M 13,63 M
SG&A Expenses — — — — —
D&A 2,20 M 1,56 M 1,59 M 1,50 M 844.000,0
Interest Expense -109.000,0 -84.000,0 -52.000,0 -77.000,0 -209.000,0
Income Tax 0,0 0,0 — -9,26 M -9,26 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 25,76 M 35,08 M 74,89 M 100,09 M 159,56 M
Total Liabilities 57,22 M 47,36 M 49,30 M 60,50 M 94,35 M
Shareholders' Equity -31,46 M -12,27 M 20,47 M 34,29 M 65,22 M
Total Debt — — — — —
Cash & Equivalents 11,58 M 8,64 M 9,43 M 19,99 M 35,61 M
Current Assets 15,31 M 11,76 M 10,70 M 25,54 M 39,14 M
Current Liabilities 12,08 M 7,28 M 7,19 M 12,11 M 14,12 M